Headline, October 29 2020/ ''' OXFORD - ''VACCINE'' - OSCAR? : UNIVERSITY



MELBOURNE LOCKDOWN LIFTED after zero virus cases. Victoria state premier declares it an ''emotional day''.

Australia's second biggest city will exit the coronavirus lockdown after nearly four months under onerous restrictions, authorities announced on Monday, with no new daily cases of or deaths recorded.

Stay-at-home orders for Melbourne's. five million residents will be lifted from midnight Tuesday into Wednesday while restaurants, beauty salons and retail stores will be permitted to throw open their doors to customers.

Melbourne, and the surrounding Victoria state, recorded its first 24-hour period without any new Covid-19 cases June 8 -before security bungles at quarantine hotels housing returned international travellers sparked a major outbreak in July.

Announcing the much anticipated relaxing of restrictions, Victoria state Premier Daniel Andrews declared it an ''emotional day''.

''This has been a very difficult year. And Victorians have given a lot and I'm proud of every single one of them,'' he told reporters in Melbourne.

Social media users declared the return to zero new cases. ''Donut Day'', with hashtag trending down under as some Twitter users posted selfies with the treats in celebration.

LONDON : OXFORD VACCINE TRIALS RAISE HOPES of virus cure. Results prove its safety, efficacy in both old and young adults.

ONE OF THE WORLD'S LEADING Covid-19 experimental vaccines produces an immune response in both old and young adults, raising hopes of a path out of the gloom and economic destruction wrought by the novel coronavirus.

The vaccine, developed by the University of Oxford, also triggers lower adverse response among the elderly, British drug maker AstraZeneca Plc, which is helping manufacture the vaccine, said on Monday.

A vaccine that works is seen as a game-changer in the battle against the novel coronavirus, which has killed more than 1.15 million people, shutterred swathes of the global economy and turned normal life upside down for billions of people.

''It is encouraging to see immunogencity responses were similar between older and younger adults and that reactogenicity was lower in older adults, where the Covid-19 disease severity is higher,'' an AstraZeneca spokesman said.

The results further build the body of evidence for the safety and immunogenicity of AZD1222,'' the spokesman said, referring to the technical name of the vaccine.

AstraZeneca. did not provide detail of the data behind behind the statement or say when it would publish eagerly awaited late-stage phase III trial data, which would show whether the vaccine works well enough in large scale trials for it to be approved.

The Oxford/AstraZeneca vaccine is expected to be one of the first from big pharma to secure regulatory approval, along with Pfizer and BioNTech's candidate.

The news that. older people. get an immune response from the vaccine is positive because the immune system weakens with age and older people are those most at risk of dying from the virus.

If it works, a vaccine would allow the world to return to some measure of. normality after the tumutt of the pandemic.

British Health Secretary Matt Hancock said a vaccine was not yet ready but he was preparing logistics for a possible roll out mostly in the first half of 2021.

Asked if some people could receive a vaccine this year he told the BBC :

''I don't rule that out but that is not my central expectation.'' 


Work began on the Oxford vaccine in January. Called AZD1222 or ChADOxI nCov-19, the viiral vector vaccine is made from weakened version of common cold virus that causes infections in chimpanzees.

Immunogenicity blood tests carried out on a subset of. older participants. echo data released in July which showed a vaccine generated 

''Robust immune responses'' in a group of healthy adults aged between 18 and 55, the Financial Times reported earlier.

''We need to see the data before concluding that the responses were similar,'' Stephen Evans, a professor of pharmacoepidemlology at London School of Hygiene and Tropical Medicine, said.

He said that. reactogenecity, which refers to common side effects of vaccines like soreness and redness of the arm, was. ''often, but not always'' associated with vaccine's. immunogenicity.

With respectful dedication to Mankind, Students, Professors and Teachers of the world. See Ya all. prepare and register for. Great Global Elections on The World Students Society : wssciw.blogspot.com and Twitter - !E-WOW! - The Ecosystem 2011 :

''' Safety - Super '''

Good Night and God Bless

SAM Daily Times - the Voice of the Voiceless


Post a Comment

Grace A Comment!